Rapid lung function decline in adults with early-stage cystic fibrosis lung disease

Elliott C. Dasenbrook(Cleveland Clinic), Nicole Mayer-Hamblett(Seattle Children's Hospital), Michael S. Schechter(Emory University), Don B. Sanders(Indiana University School of Medicine), Aliza K. Fink, Stefanie J. Millar(Pinnacle Clinical Research), David J. Pasta(Ovation Fertility)
Journal of Cystic Fibrosis
December 20, 2019
10.1016/j.jcf.2019.12.005
Cited by 3

Related Papers

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
|The Journal of Pediatrics|2007|441
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease
|JAMA|2008|377
Association Between Respiratory Tract Methicillin-Resistant S&lt;emph type="ital"&gt;taphylococcus aureus&lt;/emph&gt; and Survival in Cystic Fibrosis
|JAMA|2010|359